KIMMS
The road to the latest risk calculations by the RCPAQAP KIMMS Program
Immunology
Review of lyophilisation of external quality assurance program material
Evaluation of method discordance in a doublestranded DNA antibody external quality assurance program
Chemical Pathology
Method Bias in Calcium Measurement
Cholesterol Measurement – Unexpected Results in a Commutable EQA Program
One Size Doesn’t Fit All: Lessons from a Procalcitonin External Quality Assurance Program
Stability of RCPAQAP Blood Gas and Co-Oximetry Samples
Serology
External Quality Assurance Program for Coronavirus SARS CoV-2 Antibodies – the first 12 months
External quality assurance program for small intestine disaccharidases
Introduction of a Point of Care Ketones EQA
Australian Laboratories compliance with NPAAC requirements for Send Away Tests
Development of an Inborn Errors Dried Blood Spot External Quality Assurance Program
Molecular Genetics
Genetic Diagnosis of Acute Myeloid Leukaemia by Next Generation Sequencing
Transfusion
Transfusion Reaction Investigation EQA, a six-year review
Results from 2019 Critical Calcium Results audit
Educational Component of the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) Biogenic Amines Program
How comparable are serum indices measurements between laboratories?
Inconsistencies in Reporting Anti-Streptolysin O: A Five Year Review
Microbiology
Vancomycin Resistant Enterococci (VRE) screening quality assurance program: a five-year review of methods and performance
Haematology
Ongoing improvements in laboratory performance of coagulation factors VIII and IX: Recent experience from the RCPAQAP
Stabilising PTH within RCPAQAP Materials: Exploring the Efficacy of Mg2+, Dextran, and Triton X-100
Cytopathology
Quest for Quality in Digital Cytopathology
Anatomical Pathology
The challenges of implementing a PD-L1 proficiency testing program
Malaria Parasite Proficiency Testing - 11 year Review
High rates of variation in HLA-DQ2/DQ8 diagnostic testing: Results from an RCPAQAP coeliac disease pilot program
Review of Factor XIII Screen Versus Assay: Results from the RCPAQAP
2nd KIMMS workshop. Where to now?
Introduction of a Body Fluids External Quality Assurance Program
Stability of Lyophilised General Serum Chemistry QAP Materia
A Five-year Review: External Quality Assurance of Hereditary Haemochromatosis Testing
Icterus Assessment in an external quality assurance program
Total Pathway to Method Validation
External quality assurance within the renewed National Cervical Screening Program – a preliminary analysis
External Quality Assurance In Malarial Parasite Density Counts
Evaluation of diagnostic testing for IDH1 and IDH2 gene variants in acute myeloid leukaemia
Informatics
Informatics External Quality Assurance (IEQA) Down Under: Evaluation of a pilot implementation
Business Development
From Compliance to Excellence – the RCPAQAP and the Australian Business Excellence Framework (ABEF)
Environmental Management System Committee
Achieving Environmental Management Systems (ISO 14001) Certification at the RCPAQAP
Unfractionated Heparin monitoring with Activated Partial Thromboplastin Time – RCPAQAP Questionnaire review
RCPAQAP Pilot Program for Strongyloides Detection
Risk in Pathology as measured by KIMMS
Synovial Fluid
Preservation of Synovial Fluid with Dimethyl Sulfoxide (DMSO)
Investigating the Effects of Lyophilisation on General Serum Chemistry EQA Material for Routine Measurands
A KIMMS survey on high risk results handover
Anti-Müllerian Hormone: Results from the RCPAQAP Pilot Program
Establishment of a real-time external quality assurance program
Introduction of a calibrator category to differentiate new Troponin reagent releases
The Changing Face of Activated Protein C Resistance Testing – A 10 Year Review
Evaluating a Strongyloides EQA Program: Outcomes of a two-year pilot study
Fresh Whole Blood Immunosuppressants Program Review
The Royal College of Pathologists of Australasia Quality Assurance Programs 10 year review of INR
Challenges of producing a new external quality assurance program
Malarial Parasite Rapid Diagnostic Testing – A Performance Review
Bone Marrow Morphology Proficiency Testing – A Virtual Experience
Evaluation of a virtual ANA External Quality Assurance Challenge
Neutralisation of Rivaroxaban Induced Interference by DOAC Stop and Andexanet Alfa
Highlighting the need for harmonisation of G6PD reporting following the introduction of new antimalarials
Challenging the robustness of plasma free metanephrine methods – Are laboratories hydrolyzing samples?
Single vs Dual platform: CD34+ External Quality Assurance Program, a fi ve year review
High variation in reporting of CD21lo B cell population during a pilot external Quality Assurance Program
Investigation of a false positive codeine interference in an AACB/RCPAQAP Urine Toxicology Survey sample
Comparison of low Troponin results in a commutable EQA program
Variation in reporting of fractions in serum protein electrophoresis
The Effect of Dextran Sulfate in Heparin Monitoring Reagents
Do Point of Care Tests for Influenza & RSV Work? Four Years of Data
External Quality Assurance Challenges of a Factor XIII Deficient Sample
Inter-laboratory variation in B cells subsets reporting and its clinical implications
Method variation of Cytomegalovirus IgM assays in EQA
Method Comparison of Antibody Titre Sensitivity using RCPAQAP Datasets
Comparison of EQA variation between two Sysmex instruments over a four-year period
Analytical principle vs measurement system to assess Haemoglobinopathy EQA results
Reporting of haemolysed samples for common pathology tests
Monomeric prolactin introduction to endocrine EQA program
A five-year review of the RCPAQAP Antigen Phenotyping EQA
